Works by Shu, Yongqian

Results: 176

A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.

Published in:

Oncologist, 2024, v. 29, n. 8, p. e1012, doi. 10.1093/oncolo/oyae073

By:

Li, Jin;
Wang, Zhiqiang;
Zhong, Haijun;
He, Yifu;
Zhang, Chen;
Niu, Zuoxing;
Yang, Shujun;
Zhang, Tao;
Zhu, Liangjun;
Shu, Yongqian;
Gao, Yong;
Peng, Jianjun;
Song, Yan;
Li, Jian;
Yuan, Ying;
Zhang, Haibo;
Yu, Gengsheng;
Hua, Yunqi;
Xiao, Jianjun;
Fu, Jianfei

Publication type:

Article

Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).

Published in:

Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857

By:

Chi, Yihebali;
Shu, Yongqian;
Ba, Yi;
Bai, Yuxian;
Qin, Baoli;
Wang, Xiuwen;
Xiong, Jianping;
Xu, Nong;
Zhang, Helong;
Zhou, Jianfeng;
Xu, Jianming;
Cheng, Ying;
Feng, Jifeng;
Hu, Chunhong;
Chen, Yigui;
Chen, Zhendong;
Wang, Jufeng;
Dang, Chengxue;
Wang, Jianhong;
Wan, Yiye

Publication type:

Article

A Single‐Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer.

Published in:

Oncologist, 2019, v. 24, n. 7, p. 883, doi. 10.1634/theoncologist.2019-0164

By:

Chen, Xiaofeng;
Qiu, Tianzhu;
Zhu, Yingwei;
Sun, Jing;
Li, Ping;
Wang, Biao;
Lin, Peinan;
Cai, Xiaomin;
Han, Xiao;
Zhao, Fengjiao;
Shu, Yongqian;
Chang, Lianpeng;
Jiang, Hua;
Gu, Yanhong

Publication type:

Article

Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population.

Published in:

Scientific Reports, 2014, p. 1, doi. 10.1038/srep06700

By:

Haina Du;
Xizhi Zhang;
Mulong Du;
Nannan Guo;
Zhipeng Chen;
Yongqian Shu;
Zhengdong Zhang;
Meilin Wang;
Lingjun Zhu

Publication type:

Article

Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.

Published in:

Scientific Reports, 2013, p. 1, doi. 10.1038/srep02845

By:

Tao Zhang;
Wenjie Guo;
Yang Yang;
Wen Liu;
Lele Guo;
Yanhong Gu;
Yongqian Shu;
Lu Wang;
Xuefeng Wu;
Zichun Hua;
Yuehai Ke;
Yang Sun;
Yan Shen;
Qiang Xu

Publication type:

Article

Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women.

Published in:

Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00427

By:

Wang, Rong;
Yin, Zhiqiang;
Liu, Lingxiang;
Gao, Wen;
Li, Wei;
Shu, Yongqian;
Xu, Jiali

Publication type:

Article

Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNApositive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study).

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1232858

By:

Yizhang Chen;
Jiaguang Zhang;
Gaohua Han;
Jie Tang;
Fen Guo;
Wei Li;
Li Xie;
Hao Xu;
Xinyi Zhang;
Yitong Tian;
Lanlan Pan;
Yongqian Shu;
Ling Ma;
Xiaofeng Chen

Publication type:

Article

Prognostic value of the albuminbilirubin score in patients with non-Hodgkin lymphomaassociated hemophagocytic lymphohistiocytosis.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1162320

By:

Wanying Cheng;
Limin Duan;
Ji Xu;
Yongqian Shu;
Hongxia Qiu;
Guangli Yin

Publication type:

Article

miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 2, p. 1742, doi. 10.3892/mmr.2016.5413

By:

MINGXIA ZHU;
XIN ZHOU;
YIPING DU;
ZEBO HUANG;
JUN ZHU;
JING XU;
GONGMING CHENG;
YONGQIAN SHU;
PING LIU;
WEI ZHU;
TONGSHAN WANG

Publication type:

Article

Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 13, p. 9321, doi. 10.1245/s10434-024-16033-x

By:

Xu, Tongpeng;
Bai, Jianan;
Zhao, Kun;
Chen, Xiaofeng;
Wang, Shuhui;
Zhu, Shusheng;
Sun, Chongqi;
Zhao, Chenhui;
Wang, Ting;
Zhu, Ling;
Hu, Meizhen;
Pang, Fei;
Zhang, Junling;
Wang, Wei;
Shu, Yongqian;
Li, Fang;
Zhou, Yue

Publication type:

Article

Extracellular vesicles-mediated noncoding RNAs transfer in cancer.

Published in:

Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0426-y

By:

Pei Ma;
Yutian Pan;
Wei Li;
Chongqi Sun;
Jie Liu;
Tongpeng Xu;
Yongqian Shu

Publication type:

Article

A lipase-based electrochemical biosensor for target DNA.

Published in:

Microchimica Acta, 2014, v. 181, n. 5/6, p. 615, doi. 10.1007/s00604-014-1162-4

By:

Chen, Yangyang;
Xiao, Lin;
Liu, Ying;
Li, Xiaoxi;
Zhang, Juan;
Shu, Yongqian

Publication type:

Article

Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial.

Published in:

Advances in Therapy, 2020, v. 37, n. 11, p. 4585, doi. 10.1007/s12325-020-01477-w

By:

Li, Jin;
Guo, Weijian;
Bai, Yuxian;
Deng, Yanhong;
Yang, Lei;
Chen, Zhendong;
Zhong, Haijun;
Xu, Ruihua;
Pan, Hongming;
Shu, Yongqian;
Yuan, Ying;
Zhou, Jianfeng;
Xu, Nong;
Liu, Tianshu;
Ma, Dong;
Wu, Changping;
Cheng, Ying;
Xu, Jianming;
Chen, Donghui;
Li, Wei

Publication type:

Article

IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13473-w

By:

Ying, Shuai;
Wu, Ningxia;
Ruan, Yuting;
Ge, Wen;
Ma, Pei;
Xu, Tongpeng;
Shu, Yongqian;
Wang, Yingwei;
Qiu, Wen;
Zhao, Chenhui

Publication type:

Article

Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.

Published in:

Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01208-3

By:

Xie, Mengyan;
Yu, Tao;
Jing, Xinming;
Ma, Ling;
Fan, Yu;
Yang, Fengming;
Ma, Pei;
Jiang, Huning;
Wu, Xi;
Shu, Yongqian;
Xu, Tongpeng

Publication type:

Article

Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer.

Published in:

Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01207-4

By:

Chen, Yi;
Lin, Yu;
Shu, Yongqian;
He, Jing;
Gao, Wen

Publication type:

Article

TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.

Published in:

Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-019-1104-1

By:

Shuai, You;
Ma, Zhonghua;
Liu, Weitao;
Yu, Tao;
Yan, Changsheng;
Jiang, Hua;
Tian, Shengwang;
Xu, Tongpeng;
Shu, Yongqian

Publication type:

Article

Role of hypoxia in cancer therapy by regulating the tumor microenvironment.

Published in:

Molecular Cancer, 2019, v. 18, n. 1, p. 1, doi. 10.1186/s12943-019-1089-9

By:

Jing, Xinming;
Yang, Fengming;
Shao, Chuchu;
Wei, Ke;
Xie, Mengyan;
Shen, Hua;
Shu, Yongqian

Publication type:

Article

Genetic variants in circTUBB interacting with smoking can enhance colorectal cancer risk.

Published in:

Archives of Toxicology, 2020, v. 94, n. 1, p. 325, doi. 10.1007/s00204-019-02624-1

By:

Zhang, Ke;
Li, Shuwei;
Gu, Dongying;
Xu, Kaili;
Zheng, Rui;
Xin, Junyi;
Meng, Yixuan;
Ben, Shuai;
Chu, Haiyan;
Zhang, Zhengdong;
Shu, Yongqian;
Du, Mulong;
Liu, Lingxiang;
Wang, Meilin

Publication type:

Article

A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 12, n. 6, p. 4017, doi. 10.3892/etm.2016.3871

By:

YUANJUE SUN;
YONGQIAN SHU;
BAORUI LIU;
PING LIU;
CHANGPING WU;
RONGSHENG ZHENG;
XIAOHUA ZHANG;
ZHIXIANG ZHUANG;
YONGCHUAN DENG;
LEIZHEN ZHENG;
QING XU;
BIN JIANG;
XUENONG OUYANG;
JIANFEI GAO;
NONG XU;
XIAOYI LI;
SU JIANG;
CHAOFAN LIANG;
YANG YAO

Publication type:

Article

A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 12, n. 5, p. 3021, doi. 10.3892/etm.2016.3741

By:

YUANJUE SUN;
YONGQIAN SHU;
BAORUI LIU;
PING LIU;
CHANGPING WU;
RONGSHENG ZHENG;
XIAOHUA ZHANG;
ZHIXIANG ZHUANG;
YONGCHUAN DENG;
LEIZHEN ZHENG;
QING XU;
BIN JIANG;
XUENONG OUYANG;
JIANFEI GAO;
NONG XU;
XIAOYI LI;
SU JIANG;
CHAOFAN LIANG;
YANG YAO

Publication type:

Article

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial.

Published in:

Cancer Medicine, 2021, v. 10, n. 5, p. 1681, doi. 10.1002/cam4.3771

By:

Huang, Jing;
Xiao, Juxiang;
Fang, Wentao;
Lu, Ping;
Fan, Qingxia;
Shu, Yongqian;
Feng, Jifeng;
Zhang, Shu;
Ba, Yi;
Zhao, Yang;
Liu, Ying;
Bai, Chunmei;
Bai, Yuxian;
Tang, Yong;
Song, Yan;
He, Jie

Publication type:

Article

Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.

Published in:

Cancer Medicine, 2018, v. 7, n. 6, p. 2370, doi. 10.1002/cam4.1490

By:

Shan, Xia;
Zhang, Huo;
Zhang, Lan;
Zhou, Xin;
Wang, Tongshan;
Zhang, Jinying;
Shu, Yongqian;
Zhu, Wei;
Wen, Wei;
Liu, Ping

Publication type:

Article

CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.

Published in:

Medical Oncology, 2015, v. 32, n. 3, p. 1, doi. 10.1007/s12032-015-0499-9

By:

Qian, Yingying;
Pei, Dong;
Cheng, Ting;
Wu, Changling;
Pu, Xiaolin;
Chen, Xiaofeng;
Liu, Yiqian;
Shen, Hong;
Zhang, Weiwei;
Shu, Yongqian

Publication type:

Article

Clinical significance of PIK3CA and survivin in primary adenosquamous lung carcinoma.

Published in:

Medical Oncology, 2014, v. 31, n. 6, p. 1, doi. 10.1007/s12032-014-0983-7

By:

Yu, Shaomin;
Zhang, Zhihong;
Zhang, Bin;
Shu, Yongqian;
Wu, Hao;
Huang, Xiang;
Yu, Qianqian;
Guo, Renhua

Publication type:

Article

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Published in:

Medical Oncology, 2012, v. 29, n. 1, p. 384, doi. 10.1007/s12032-010-9797-4

By:

Zhu, Wei;
Zhu, DanXia;
Lu, Shiqiang;
Wang, Tongshan;
Wang, Jian;
Jiang, Binghua;
Shu, Yongqian;
Liu, Ping

Publication type:

Article

Integrated Multi-omics Data Analysis and In Vitro Validation Reveal the Crucial Role of Glycogen Metabolism in Gastric Cancer.

Published in:

Journal of Cancer, 2025, v. 16, n. 4, p. 1243, doi. 10.7150/jca.104424

By:

Xin Zhou;
Jing Wu;
Yaoyao Liu;
Xiaping Wang;
Xuan Gao;
Xuefeng Xia;
Jing Xu;
Jing He;
Tongshan Wang;
Yongqian Shu

Publication type:

Article

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28408-3

By:

Xu, Jianming;
Li, Yi;
Fan, Qingxia;
Shu, Yongqian;
Yang, Lei;
Cui, Tongjian;
Gu, Kangsheng;
Tao, Min;
Wang, Xiuwen;
Cui, Chengxu;
Xu, Nong;
Xiao, Juxiang;
Gao, Quanli;
Liu, Yunpeng;
Zhang, Tao;
Bai, Yuxian;
Li, Wei;
Zhang, Yiping;
Dai, Guanghai;
Ma, Dong

Publication type:

Article

A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.

Published in:

Journal of Biomedical Research, 2019, v. 33, n. 3, p. 173, doi. 10.7555/JBR.32.20160030

By:

Haina Du;
Guoxin Song;
Mingzhi Fang;
Yongqian Shu;
Xin Zhao;
Lingjun Zhu

Publication type:

Article

Investigation of combination therapy modes of bevacizumab and paclitaxel for NSCLC in vivo.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2016, v. 29, p. 695

By:

Jian Wang;
Hua Shen;
Qian Jiang;
Yongqian Shu

Publication type:

Article

Wilms’ tumor 1 enhances Cisplatin‐resistance of advanced NSCLC.

Published in:

FEBS Letters, 2014, v. 588, n. 24, p. 4566, doi. 10.1016/j.febslet.2014.10.026

By:

Wu, Chen;
Wang, Yonggong;
Xia, Yang;
He, Shaohua;
Wang, Zhiqiang;
Chen, Yijiang;
Wu, Changping;
Shu, Yongqian;
Jiang, Jingting

Publication type:

Article

MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.

Published in:

FEBS Letters, 2014, v. 588, n. 7, p. 1168, doi. 10.1016/j.febslet.2014.02.054

By:

Qiu, Tianzhu;
Zhou, Xin;
Wang, Jian;
Du, Yiping;
Xu, Jun;
Huang, Zebo;
Zhu, Wei;
Shu, Yongqian;
Liu, Ping

Publication type:

Article

METTL14 regulates CD8+T-cell activation and immune responses to anti‐PD‐1 therapy in lung cancer.

Published in:

World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03402-9

By:

Sun, Chongqi;
Wang, Jian;
Li, Huixing;
Liu, Luyao;
Lin, Yu;
Zhang, Ling;
Zu, Xianglong;
Zhu, Yizhi;
Shu, Yongqian;
Shen, Dong;
Wang, Qiong;
Liu, Yiqian

Publication type:

Article

Micro RNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.

Published in:

FEBS Journal, 2012, v. 279, n. 20, p. 3800, doi. 10.1111/j.1742-4658.2012.08741.x

By:

Liu, Lingxiang;
Shao, Xiaoyan;
Gao, Wen;
Zhang, Zhi;
Liu, Ping;
Wang, Rongsheng;
Huang, Puwen;
Yin, Yongmei;
Shu, Yongqian

Publication type:

Article

Genome-Wide Association Study Identifies a Novel Susceptibility Locus at 12q23.1 for Lung Squamous Cell Carcinoma in Han Chinese.

Published in:

PLoS Genetics, 2013, v. 9, n. 1, p. 1, doi. 10.1371/journal.pgen.1003190

By:

Jing Dong;
Guangfu Jin;
Chen Wu;
Huan Guo;
Baosen Zhou;
Jiachun Lv;
Daru Lu;
Yongyong Shi;
Yongqian Shu;
Lin Xu;
Minjie Chu;
Cheng Wang;
Ruyang Zhang;
Juncheng Dai;
Yue Jiang;
Dianke Yu;
Hongxia Ma;
Xueying Zhao;
Zhihua Yin;
Lei Yang

Publication type:

Article

A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors.

Published in:

2020

By:

Liu, Yiqian;
Liu, Lianke;
Liu, Lingxiang;
Wang, Tongshan;
Guo, Lian;
Wang, Yixiang;
Gao, Zhengzhen;
Shu, Yongqian

Publication type:

journal article

Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 5, p. 1287, doi. 10.1007/s00280-013-2127-8

By:

Zhao, Wan;
Hu, Lingmin;
Xu, Jiali;
Shen, Hongbing;
Hu, Zhibin;
Ma, Hongxia;
Shu, Yongqian;
Shao, Yongfeng;
Yin, Yongmei

Publication type:

Article

Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 5, p. 1159, doi. 10.1007/s00280-013-2108-y

By:

Wu, Hao;
Huang, Min;
Lu, Mingjie;
Zhu, Wei;
Shu, Yongqian;
Cao, Peng;
Liu, Ping

Publication type:

Article

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 723, doi. 10.1007/s00280-011-1752-3

By:

Zhu, Wei;
Xu, Huaguo;
Zhu, DanXia;
Zhi, Hui;
Wang, Tongshan;
Wang, Jian;
Jiang, Binghua;
Shu, Yongqian;
Liu, Ping

Publication type:

Article

IL-17 induces NSCLC A549 cell proliferation via the upregulation of HMGA1, resulting in an increased cyclin D1 expression.

Published in:

International Journal of Oncology, 2018, v. 52, n. 5, p. 1579, doi. 10.3892/ijo.2018.4307

By:

Zhao, Chenhui;
Li, Yongting;
Zhang, Weiming;
Zhao, Dan;
Ma, Ling;
Ma, Pei;
Yang, Fengming;
Wang, Yingwei;
Shu, Yongqian;
Qiu, Wen

Publication type:

Article

Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis.

Published in:

BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/9271215

By:

Yang, Fengming;
Qin, Zhiqiang;
Shao, Chuchu;
Liu, Weitao;
Ma, Ling;
Shu, Yongqian;
Shen, Hua

Publication type:

Article

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.

Published in:

Drug Design, Development & Therapy, 2016, v. 10, p. 241, doi. 10.2147/DDDT.S88743

By:

Jing Qian;
Yingying Qian;
Jian Wang;
Bing Gu;
Dong Pei;
Shaohua He;
Fang Zhu;
Røe, Oluf Dimitri;
Jin Xu;
Lianke Liu;
Yanhong Gu;
Renhua Guo;
Yongmei Yin;
Yongqian Shu;
Xiaofeng Chen

Publication type:

Article

Functional genetic variant of HSD17B12 in the fatty acid biosynthesis pathway predicts the outcome of colorectal cancer.

Published in:

Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 24, p. 14160, doi. 10.1111/jcmm.16026

By:

Lin, Yu;
Meng, Yixuan;
Zhang, Jinying;
Ma, Ling;
Jiang, Lu;
Zhang, Yi;
Yuan, Ming;
Ren, Anjing;
Zhu, Weiyou;
Li, Shuwei;
Shu, Yongqian;
Du, Mulong;
Zhu, Lingjun

Publication type:

Article

Safety, efficacy, and pharmacokinetics of SH‐1028 in EGFR T790M‐positive advanced non–small cell lung cancer patients: A dose‐escalation phase 1 study.

Published in:

Cancer (0008543X), 2023, v. 129, n. 10, p. 1513, doi. 10.1002/cncr.34697

By:

He, Jing;
Ma, Pei;
Zhao, Dongmei;
Shi, Xinsheng;
Guo, Renhua;
Gao, Wen;
Shu, Yongqian

Publication type:

Article

KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression.

Published in:

2017

By:

Sun, Chongqi;
Ma, Pei;
Wang, Yanfen;
Liu, Weitao;
Chen, Qinnan;
Pan, Yutian;
Zhao, Chenhui;
Qian, Yingchen;
Liu, Jie;
Li, Wei;
Shu, Yongqian

Publication type:

journal article

miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1.

Published in:

Pathology & Oncology Research, 2013, v. 19, n. 4, p. 677, doi. 10.1007/s12253-013-9630-4

By:

Zhou, Li;
Qiu, Tianzhu;
Xu, Jing;
Wang, Tongshan;
Wang, Jian;
Zhou, Xin;
Huang, Zebo;
Zhu, Wei;
Shu, Yongqian;
Liu, Ping

Publication type:

Article

Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2015, v. 27, n. 4, p. 221, doi. 10.1179/1973947815Y.0000000005

By:

Zhu, Weiyou;
Røe, Oluf Dimitri;
Wu, Chen;
Li, Wei;
Guo, Renhua;
Gu, Yanhong;
Liu, Yiqian;
Shu, Yongqian;
Chen, Xiaofeng

Publication type:

Article

Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients.

Published in:

Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.608742

By:

Zhu, Chunrong;
Zhu, Liangjun;
Gu, Yanhong;
Liu, Ping;
Tong, Xiaoling;
Wu, Guozhong;
Zhu, Wenyu;
Shen, Wenxiang;
Bao, Hua;
Ma, Xiangyuan;
Yu, Ruoying;
Wu, Xue;
Zhu, Dongqin;
Shu, Yongqian;
Feng, Jifeng

Publication type:

Article

Metabolic disposition of [14C]‐abivertinib, an epidermal growth factor receptor tyrosine kinase inhibitor: Role of glutathione conjugation.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1475, doi. 10.1111/bcp.14555

By:

Wang, Lu;
Guo, Lian;
Wang, Yixiang;
Guo, Renhua;
Xu, Zhaoqiang;
Gao, Zhengzhen;
Xie, Lijun;
Chen, Juan;
Chen, Ying;
Liu, Yun;
Zhang, Hongwen;
Bao, Lihua;
Xu, Wanhong;
Zhu, Mingshe;
Shao, Feng;
Shu, Yongqian

Publication type:

Article

An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes.

Published in:

OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2303195

By:

Ying, Leqian;
Hu, Zhangmin;
Lu, Yi;
Tao, Qing;
Xiong, Fen;
Shu, Yongqian;
Yang, Yufei;
Qiao, Xuehan;
Peng, Chen;
Jiang, Yuchun;
Han, Miao;
Xu, Min;
Li, Xiaoqin;
Wang, Deqiang

Publication type:

Article